Additional file 1 of miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5

Additional file 1: Figure S1. miR-198 does not affect the cell cycle. (A,B) A498 and ACHNcells were transfected with scrambled mimic of miR-198 and wild-type miR-198. After 36 h, the cells were analyzed using flow cytometry to assess their cell cycle. NS = no significant. (C,D) ACHNcells were treated like (A). NS = no significant.